Market Access Changing Faces: Agency, consultancy, and investor hires for ... Just a quick write-up this month for agency, consultancy, and investor hires.
Sales & Marketing Changing Faces – Agency, consultancy, and investor hires fro... Welcome back to Changing Faces for the month of July.
Sales & Marketing Changing Faces May-June 2024: Agency, consultancy, and inves... For a super-sized hires round-up, our list of hires in the agency and consultancy world for May and June is surprisingly concise.
Sales & Marketing Changing Faces: Agency, consultancy, and investor hires from... With apologies for the lateness, we didn’t want to miss the opportunity to acknowledge the many moves in the pharma agency space in April.
Sales & Marketing Changing Faces: Agency, consultancy, and investor hires from... Another light month in March on the agency and investor side, but there are a few appointments worth noting.
Sales & Marketing Changing Faces: Agency, consultancy, and investor hires from... We had a light month for hires in February in the agency, consultancy, and investor worlds. But we did have a few notable job changes cross the wire.
News First global approval for Daiichi Sankyo's Dato-DXd Daiichi Sankyo has claimed its first approval, in Japan, for TROP2-targeting antibody-drug conjugate (ADC) datopotamab deruxtecan.
Digital Sponsored The AI effect in pharma commercial strategy: From data to re... Discover how AI is transforming the pharma commercial strategy. Unlock real-time insights & actions from data. Click here for more.
